International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing more...
Author Details :
Volume : 8, Issue : 1, Year : 2021
Article Page : 40-47
Cancer also known as malignant neoplasm, is a broad group of various diseases. In cancer, cells divide and grow uncontrollably, forming malignant tumours, and invade nearby parts of the body. There are over 200 different known cancers that afflict humans. Malignant neoplastic lesions are the eighth leading cause accounting for 6.7% of the total medically certified deaths in India. Breast cancer is by far the most frequent cancer among women with an estimated 2.58 million new cancer cases diagnosed in 2019 (23% of all cancers), and ranks second overall (10.9% of all cancers). It is now the most common cancer both in developed and developing regions with around 690000 new cases estimated in each region (population ratio1:4). Breast cancer is the Most Common cancer in all urban areas in India, and 2nd most common in the rural areas. The most recent data Population Based Cancer Registry PBCR 2016 - 2018 tells us that breast cancer accounts for 25% to 31% of all cancers in women in cities(Mumbai, Delhi, Chennai, Ahmedabad, Bengaluru, Bhopal etc.). Breast cancer alone accounts for around 14% of total female neoplasm deaths.
Keywords: Serum ferritin, Lactate dehydrogenase, Gamma Glutamyltransferase.
How to cite : Jagannadha Phaneendra D S, Deepak C S N , Mahmood S , Serum ferritin, lactate dehydrogenase, and gamma glutamyl transferase levels in patients with breast carcinoma. Int J Clin Biochem Res 2021;8(1):40-47
Copyright © 2021 by author(s) and Int J Clin Biochem Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License (creativecommons.org)